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Abstract 
Butyl Rubber (RB) is a copolymer of isobutylene (IB) with small percentages of isoprene 
(IP). Typically these IP units serve as sites for the covalent cross-linking of the rubber, but 
they can also serve as sites to further functionalize RB. These modifications can expand the 
potential applications of RB. This thesis describes the synthesis of carboxylic acid 
functionalized RB and some properties and applications of these materials. Several avenues 
of RB functionalization were studied such as cyclic anhydride ring opening, thiol-ene 
chemistry, ring opening polymerization and ATRP graft polymerizations to provide RB with 
varying carboxylic acid content. The most successful methods were the cyclic anhydride ring 
opening and ATRP polymerization of tert-butyl methacrylate followed by removal of the 
tert-butyl group. The adhesion of the resulting polymers to metal surfaces was studied and it 
was found that the carboxylic acids as well as other oxygenated rubber derivatives leading up 
to them led to enhanced adhesion. They also provided compatibilization properties that 
allowed for the deposition of hydrophilic polymers on butyl rubber. Lastly, the anti-
proliferative drug Paclitaxel was covalently conjugated to the carboxylic acid functionalized 
rubber to provide a sustained release in comparison to physically encapsulated drug, leading 
to promising potential in stent coating applications.  
 
Keywords 
butyl rubber, cyclic anhydride ring opening, thiol-ene, ATRP, paclitaxel, drug release, 
surface adhesion, compatibilization, stent coating 
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Chapter 1  
Polymers used in the production in biomaterials  
1.1 General Introduction  
The field of biomaterials is a vast and ever changing field that encompasses the 
improvement and extension of life through materials.  There are many different 
definitions of biomaterials, but a common theme is the use of materials to improve or 
replace function within a biological system. These materials vary in function, structure 
and importance.  Early examples of biomaterials like wooden teeth and glass eyes were 
crude but served their purpose 1. Upon the advent of polymers at the end of the nineteenth 
century, polymers became increasingly integrated within medical applications 2. Some 
early examples were the use of poly(methyl methacrylate) (PMMA), in dentistry 3 as well 
as in coatings for hip-replacements.   Another example was the use of polyether urethanes 
in the production of artificial hearts 1, 3.  
Examples of biomaterials can be both medical and non-medical and also these 
materials can be either natural or synthetic. Thus for simplicity, biomaterials can be 
divided into two-sub groups, which are not mutually exclusive - structural and functional 
biomaterials. An example of structural biomaterials is the glass eye that fills the cavity in 
which the eye used to be, but does not replace sight. This material fulfills the structural 
requirements for the eye to protect the eye socket from the outside surroundings. Other 
examples of structural biomaterials include artificial bone and artificial limbs. Functional 
biomaterials on the other hand interact with the biological system to replace or enhance 
function other than structural support. Such materials can serve many functions but some 
examples are artificial organs 4, pacemakers and controlled release implants 1.  
Common issues have been addressed within all biomaterials. These issues are 
critical to the improvement and expansion of biomaterials for explicit applications. They 
include improved biocompatibility, mechanical properties and degradation 5. The 
synthetic modification of polymer microstructures can create new classes of materials 
that can reduce or eliminate the above-mentioned concerns. Using new methodologies, 
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materials can be created that are more biocompatible, responsive, stealthy and specific.  
Research is plentiful in researching materials for specific applications for both medical 
and non-medical materials.  
1.2 Vascular Stents 
An excellent example of the evolution of a biomaterial from purely structural to 
functional is the advancement in medical implants, especially coronary stents. In 1977 the 
use of balloon inflations to reduce coronary lesions was a medical breakthrough, but this 
only served as a temporary solution 6. Restenosis rates were very high after treatment 
with balloon angioplasty due the recoil effect of the vessels and constrictive remodeling.  
It became quite evident that the insertion of a structural scaffold was needed to ensure the 
vessel remained open. The insertion of metallic stents reduced the recoil phenomenon at 
both acute and chronic levels.  However, the bare metal stents (BMS) caused unavoidable 
vessel damage due to the pathological biological cascade, which caused thickening of the 
blood vessel (Figure 1.2.1b) 7. The late luminal loss limits the long-term efficacy of BMS. 
This also caused issues of thrombosis and blood clotting. The restenosis rates for BMS 
ranged between 20 and 40%, which was an improvement from rates of 40 to 60% for 
vessels not stented 8. These rates are also very dependent on the patient and 
previous/current medical conditions such as diabetes.  
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Figure 1.2.1 Cross-sectional images of porcine coronary arteries with stent explants, a) a 
polycarbonate urethane-coated stent exhibiting substantial inflammation and proliferation 
(2 months), b) a bare metal stent at 3 months showing some restenosis and c) 
poly(styrene)-co-poly(isobutylene)-co-poly(styrene) (SIBS) coated stent at 180 days 
showing resilience 9. 
Drug-eluting stents (DES) are a means of providing mechanical integrity to the 
blood vessel but retain blood flow by means of pharmacotherapy to inhibit in-stent 
restenosis response as well as early thrombosis (Figure 1.2.1c).  A decade of clinical use 
of the first generation DES has afforded overwhelming support of the clear benefits DES 
exhibit over their BMS counterparts 10, 11. There are two first generation DES that are 
based on two different drugs, sirolimus and paclitaxel. These stents have been 
commercialized under the name CYPHER (sirolimus) and TAXUS (paclitaxel-PTx). As 
a result of the numerous clinical trials that have been completed, there are some concerns 
involving DES 12, 13. Restenosis has still been observed as well as poor re-
endothelialization 14, delayed healing 15 and tissue growth 16 behind the polymeric film 
causing thrombosis.  
a) b) c) 
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Figure 1.2.2 Function of Sirolimus and Paclitaxel in halting cell proliferation and 
different points of the cell cycle as the body identifies the arterial injury 17.  
When constructing a DES, there are several parameters to consider such as the 
choice of drug, polymer, and scaffold composition. The drugs used in the two DES that 
are approved for clinical use are sirolimus and paclitaxel (PTx), which have very 
different mechanisms. The drugs selected interfere with cell proliferation at different 
steps, but yield a similar result, which is inhibition of cell proliferation. Sirolimus 
(rapamycin) is a natural macrocyclic, lipophilic lactone with immunosuppressive 
antibiotic activity. The molecule was initially isolated in the mid-1970’s from 
Streptomyces hygroscopicus found in soil samples from the Easter Islands 18. Sirolimus 
showed excellent antimicrobial and antifungal activity but this was further exceeded by 
its immunosuppressive properties. From a therapeutic point of view, the sirolimus 
molecule binds to a specific class of cytosolic proteins called immunophiles. The receptor 
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is the FK binding protein 12 and this results in inhibition of regulatory signal transduction 
kinase. This in essence shuts down cell proliferation at the G1-S checkpoint (Figure 
1.2.2) 19-21. Alternatively, paclitaxel is a diterpenoid with a taxane skeleton. The drug 
inhibits the cell proliferation by stabilizing the microtubules, thus the cell is not released, 
which halts the cell cycle in the M phase (Figure 1.2.2) 15. PTx inhibits the growth of 
cells by its cytotoxic and antineoplastic properties. Paclitaxel gave a remarkable 
reduction in neointimal hyperplasia in animal studies and this led to its use in DES 22, 23. 
The aforementioned DES drug release profiles have been studied thoroughly and release 
has been controlled to some degree, through loading of different weight percentages 24 
(wt.%) of drugs and modifications of the drug carrier 25, 26. The resultant release profiles 
can be seen in Figure 1.1.3a where the release is tuned from slow to rapid through 
alerting the wt.% of PTx relative to the amount of SIBS utilized 24. Alternatively, as seen 
in Figure 1.1.3b the release profile can be modified by the introduction of more 
hydrophilicity. This was accomplished by the introduction of poly(styrene-co-maleic 
anhydride) (SMA) as part of the polymer mixture 26. As seen in the release profile, upon 
increasing the amount of SMA the release of PTx is much quicker than its only SIBS 
counterpart (Figure 1.2.3).  
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Figure 1.2.3 Control of drug release via a) control of wt.% of drug to polymer 24 and b) 
manipulation of the SIBS backbone by the introduction of hydrophilic entities i.e. poly 
(styrene-co-maleic anhydride (SMA) 26.  
The TAXUS stent platform uses a robust mechanically tough elastomer to support 
the enormous stresses within a biological system. The TAXUS DES utilizes a triblock 
copolymer, poly(styrene)-co-poly(isobutylene)-co-poly(styrene) (SIBS) that exhibits the 
required mechanical properties for use in vivo (Figure 1.2.4a) 27. The CYPHER DES 
employs a poly(ethylene-co-vinyl acetate) (PEVA) and poly(n-butyl methacrylate) 
(PBMA) mixture, which is also a robust polymer much like PS-PIB (Figure 1.2.4b) 17. 
SEM images show the compressed and expanded stent structures and why an elastomeric 
polymer is needed for such movements (Figure 1.2.4c-e) 26. These materials are known to 
be durable, but they are limited by low adhesion to the metal, which can cause 
delamination of the polymer from the metal stent, causing thrombosis 28, 29. Also, it has 
been illustrated that such materials can exhibit erratic release profiles 30, 31. Alternative 
a)#
b)#
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DES systems have been studied such as biodegradable polymer systems. These materials 
have several advantages but again several limitations. An example is the JACTAX HD 
DES, which uses polylactide 32. This polymer undergoes degradation by hydrolysis and 
enzymatic activity. The degradation products are eventually metabolized to water and 
carbon dioxide. The limitation with ester hydrolysis is the random cleavage sites that 
cause burst release of drug. Once significant degradation has occurred, the bottom layer 
is a BMS, which will cause the problems outlined above. Lastly, the biodegradable 
polymers do not have the ideal mechanical properties needed for the constant wear in 
vivo 33. These stents have similar rates of restenosis as the durable elastomeric DES 32, 34, 
35. Similar rates of restenosis have also been seen for the polymer free versions of DES 34, 
36. 
 
Figure 1.2.4 Chemical composition of drug/polymer for the two commercialized DES a) 
TAXUS and b) CYPHER. c) through e) show SEMs of a DES coated with 25% PTx/ 
30% SMA/ 455 SIBS c) unexpanded stent at X40 magnification d) X40 magnification of 
an expanded stent e) X200 magnification of an expanded stent 26. 
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 The studies of DES are multi-faceted and very intricate in terms of polymer and 
drug selection. Each decision alters the way the stent affects the therapeutics of the DES.  
The current commercial DES has disadvantages such as delamination and burst release, 
but these issues can be optimized. Through optimization, the DES should be able to 
capitalize on its excellent mechanical properties.  
1.3 Butyl Rubber  
1.3.1 Introduction  
Butyl rubber (RB) is a synthetic elastomer that is a copolymer of isobutylene and 
a small amount of isoprene. The IP units serve as sites for cross-linking. The most 
common commercial method of cross-linking is the process of vulcanization, which 
entails treatment with sulfur and heat. The first polymerizations of isobutylene were 
completed in 1873 but only produced low Mw polymers until I. G. Farben in Germany 
synthesized higher Mw poly(isobutylene) (PIB) by lowering the polymerization 
temperature. PIB was synthesized at -75 °C and using boron trifluoride as a catalyst. PIB 
had no commercialization potential because it was fully saturated and could not be cross-
linked 37. Poly(isobutylene-co-isoprene) (RB) was synthesized by Standard Oil 
Development Co. in 1937. The polymer was first synthesized using 1,3 butadiene but it 
was later found that isoprene was a better comonomer. The technologies developed 
played great importance during World War II because of the curtailed supply of natural 
rubber. For its time, the commercialization of RB was a scientific and engineering marvel 
due to the complexity of the technology. 
  RB possesses many attractive properties such as gas/water impermeability, 
chemical stability, excellent mechanical properties and biocompatibility 38, 39. Many of 
these properties arise from the low degree of unsaturation amongst the long PIB chains.  
The first major commercial use of RB was in tires, due to its gas/water impermeability 
and this continues to be a major market.  In addition to the tire industry, RB is used in 
other applications such as pharmaceutical stoppers, sealants, bladders, and adhesives. 
These applications take advantage of the other attractive properties of RB such as 
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resistance to UV degradation, oxidation and ozone but also its dampening and thermal 
stability.  
1.3.2 Synthesis 
Butyl rubber is synthesized from very pure monomers, isobutylene (IB) (2-
methylpropene, >95%) and isoprene (2-methyl-1,3-butadiene, >98%) (IP). The 
mechanism is consistent with a highly complex cationic polymerization 40-42. Water and 
oxygenated organic molecules are minimized due to their interference with the cationic 
polymerization process. The reaction utilizes a Lewis acid catalyst system (co-initiator 
and initiator). Typical Lewis acid co-initiators include aluminum trichloride, 
alkylaluminum dichloride, boron trifluoride, tin tetrachloride and titanium tetrachloride. 
Initiators used are commonly Brønsted acids such as water, hydrochloric acid, organic 
acids, though alkyl halides can also be used.  
 
Scheme 1.3.1 Generic scheme of the cationic polymerization of RB.  
Initiation occurs when an isobutylene monomer reacts with the Lewis acid to 
produce a carbenium ion. Monomer and comonomer units are added to the carbenium ion 
as the propagation continues. Various parameters such as solvent polarity, temperature 
and counter ions must be considered due to the way they affect the propagation. The rate 
of propagation has been determined to be around 108 L/(mol•s), essentially diffusion 
limited 43, 44. Low polymerization temperatures give higher polymerization rates in either 
hydrocarbon or halogenated solvents. The propagation step continues until there is a 
chain transfer or termination.  
 For chain transfer to occur, the carbenium ion end must react with isobutylene, 
isoprene, or species with unshared electrons. These species could include solvents, 
counterions and olefins.  Once the carbenium reacts with theses species, it terminates the 
growth of the macromolecule and facilitates a new chain. Activation energy of chain 
transfer is larger than propagation. Therefore molecular weight (MW) is strongly 
+
Lewis acid initiator system
CH3Cl, -78 °C
IP IB
mn
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influenced by temperature. The issue of chain transfer is more evident upon synthesizing 
higher IP content RB. Upon raising the IP content, lower MW co-polymers are observed 
due to the comonomers' own affinity to chain transfer 45. Alternatively, in chain 
termination the carbenium ion and its counter ion collapse, which results in destruction of 
the active chain. Termination can occur through several avenues such as hydride 
abstraction from comonomer, formation of stable allylic carbenium ions or reactions with 
the carbenium ion involving nucleophiles.  
1.3.3 Chemical & Physical Properties  
Isobutylene polymerizes in a regular head-to-tail fashion to produce a polymer 
with quaternary carbons atoms with two-pendant methyl groups’, which produces steric 
strain between other polymerized portions of isobutylene. This is partially relieved by 
distortion of the methylene carbon to 124° as compared to 110° for a tetrahedral carbon 
and also through the dihedral angle of the carbon-carbon bond by approximately 25° 46-48. 
The isoprene is polymerized in a head-to-tail arrangement leading to a predominantly 
1,4-addition (90-95%) 49. The other IP species are identified spectroscopically as 1,2 
enchained 49 or as branched 1,4-addition 50, 51. The percentage of IP can be tuned from 
low (0.5%) to high (7.0%). With these low amounts of IP and similar reactivity ratios, a 
random distribution of IP is found throughout RB. Polydispersity indices (PDI) for these 
copolymers are typically in the range of 2-5 (Mw/Mn). Also, the typical glass transition 
point of RB has been found to be -65 °C 52 (Table 1.3.1). Due to the very hydrophobic 
nature of the polymer, this affords the polymer excellent chemical inertness especially to 
UV degradation and oxidation. RB has been known to be degraded by atmospheric ozone 
over extended periods of time but this can be prevented by introduction of antioxidants. 
The chemical properties make this polymer relevant for its current and future 
applications.  
 The physical properties of PIB and its copolymers such as RB allow it to be used 
in many commercial products. RB and other variations show low permeability to small 
molecule diffusants such as He, H2, O2, N2, and CO2.  This is a result of the efficient 
intermolecular packing, which leads to a relatively high density 53-55. The efficient 
packing of the isobutylene portions allows for low fractional volumes and low diffusion 
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coefficients for penetrants. Table 1.3.1 shows tabulated data of some important physical 
properties of RB.  
Table 1.3.1 Physical properties of RB 56. 
Property Value 
Density (g/cm3) 0.917 
Glass Transition, Tg (°C) -75 to -67 
Heat Capacity, Cp (kJ/kgK)b 1.95 
Refractive Index, np 1.5081 
The low diffusion rates for various gases are shown in Table 1.3.2. The 
differences can be seen when comparing RB to NR, which is a polymer of cis-1,4-
polyisoprene. The increase in diffusivity of gases can be rationalized by looking at the 
structures of RB compared to NR. NR cannot pack as efficiently as RB due to the lack of 
flexibility of the backbone. This makes RB and its associated co-polymers especially 
useful in some commercial applications.  
Table 1.3.2 Diffusivity of several gases in RB and NR at 25 °C 57.  
Gas 
Diffusivity (cm2/s) x 106 
Butyl Rubber Natural Rubber 
He 5.93 21.6 
H2 1.52 10.2 
O2 0.081 1.6 
N2 0.045 1.1 
CO2 0.058 1.1 
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 Another attractive property is RB’s biocompatibility and being inert to various 
tissues 38, 39. RB and its derivatives are used in numerous applications such as chewing 
gum, pharmaceutical stoppers and DES, where it comes into direct contact with different 
biological environments  58. The bioinert property arises from the very hydrophobic 
nature of the polymer itself and again its low diffusivity. Thus the material being bioinert 
comes from the RB backbone being chemically inert and stable. However, there are some 
fundamental limitations to using RB for biomaterials, such as protein adsorption and 
growth of pathogenic species in certain applications 59.  
1.3.4 Modifications of Butyl Rubber  
Shortly after the advent of RB, there were investigations into how to instill 
increased polarity and the ability to cross-link it, referred to as curing, with other 
elastomers. Goodrich first synthesized halogenated RBs in the mid 1950’s by reacting RB 
with N-bromosuccinimide 60. Eventually this method was improved to use elemental 
bromine by Polymer Co. of Canada (Scheme 1.3.2). Also, in 1961 chlorinated RB was 
commercialized by Exxon and was synthesized by continuous chlorination of a solution 
of butyl rubber 61. The production of halogenated butyls expanded the application of butyl 
rubber due to its increased vulcanization rates and improved compatibility with other 
highly unsaturated elastomers (NR). 
 
Scheme 1.3.2 Synthetic pathway to yield bromo-butyl/ chloro-butyl using elemental 
halogens to yield three potential isomers. 
 With the synthesis of these halogenated RBs, further modification and alternatives 
to cross-linking were investigated. Cross-linking can be completed with halogenated RBs 
in other ways than the conventional vulcanization 62. These halogenated RBs can be 
+ X2
X= Cl, Br X + X
X
H H X
X
n m n m
mnmnmn
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cross-linked using hydrogen peroxide 63, moisture curing 64 and transition metals like zinc 
oxide 65. Beyond alternatives to conventional cross-linking, there was also a focus on 
manipulation of the butyl backbone to modify the chemical/physical properties. The 
halogenated RBs have been used in numerous examples to produce various 
functionalities off the RB backbone. Through the manipulation of the halogenated RB the 
installation of amine 66, 67, esters 68, 69, ether 70, acids 71, sulfuration 72 and ammonium/ 
phosphonium bromide ionomers 73-76 have been successfully achieved. The installations 
of ionmeric molecules are of specific interest due to their altered properties.  To install 
the ammonium/phosphonium bromide ionomers either triphenylphosphine (PPh3) or 
N,N-dimethyloctylamine (DMOA) 76 displaces the bromine to form the corresponding 
salt (Scheme 1.3.3). These polymers have shown interesting properties in terms of 
increased antimicrobial efficacy and increased adhesion to various substrates compared to 
its starting bromo-butyl.  
 
Scheme 1.3.3 Synthetic pathway in the production of cationic ionmers and conjugated 
dienes through reactions with bromo-butyl.  
The installation of acid moieties should increase some properties required for 
certain applications like increased surface adhesion to metal substrates. 
Dehydrohalogenation of the allylic bromo-butyl yielded the conjugated diene that can be 
used in the Diels-Alder cycloddition of maleic anhydride 71. The cyclo adduct can be 
attacked by an alcohol to yield an ester and an acid. The use of hydroxyl terminated 
polymers yielded graft copolymers with acid functionalities (Scheme 1.3.4). This reaction 
Br
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Br
NMe2R
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- HBr
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was limited due to the number of steps, the extreme conditions that were used, and also 
the mixture of resulting products as the conversion was not clean.  
 
Scheme 1.3.4 Cycloaddition in a Diels Alder fashion to yield a grafted acid 
functionalized RB.  
 Work has also been completed on modification of the RB backbone directly. 
There have been numerous methods of epoxidation reported in the literature 77-79. 
Recently a synthetic pathway in which poly(ethylene oxide) (PEO) was attached to RB 
using a clean and mild synthetic pathway 78, 79. Graft copolymers had previously been 
synthesized using halogenated RB but these reactions required halide substitution, a 
reaction that requires high temperatures and yields multiple products 70, 80, 81. The newer 
synthetic pathway involved the introduction of an epoxide utilizing m-
chloroperoxybenzoic acid (m-CPBA), which cleanly yielded the epoxide ring. Upon 
treatment of the epoxide under acidic conditions, the ring opened giving an alcohol. The 
surprising result was the structure of the alcohol, which was a product of the elimination 
reaction to yield an alkene. In contrast to Saytzeff’s law, the less substituted product was 
formed. This alcohol was then activated with 4-nitrophenylchloroformate and reacted 
with either hydroxyl or amine terminated PEO to yield the resultant graft copolymers 
(Scheme 1.3.5) 78, 79.  
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Scheme 1.3.5 Synthetic pathway to yield PEO co-polymers grafted off of RB through 
manipulation of the RB backbone.  
1.3.5 Applications  
 The majority of RB applications are tied closely with the automotive industry, 
involving tires and other automotive parts. RB and its modified polymers are used 
extensively in the innerliner. The tire innerliner typically consists of halobutyl due to its 
excellent air and moisture impermeability, fatigue resistance and durability. Bromobutyl 
is advantageous over chlorobutyl for many reasons, including superior adhesion to steel, 
better balance properties, fuel efficiency and lower costs 52. RB is commonly used in 
innertubes. This is due to incompatibility with other rubbers such as NR. The sidewalls 
and treads generally consist of mixtures of NR and butadiene rubber. RB is also 
commonly used in many automotive parts that require RB's special blend of properties. In 
terms of hosing in an automobile, it requires an elastomer that is resistant to the material 
it is transporting, possesses low permeability and thermal stability. RB based applications 
include air conditioning hoses, coolant hoses, fuel line hoses and brake line hoses. RB is 
also utilized in dynamic parts within an automobile, many of the mounts use RB due to 
its ability to damp vibrations 52. These vibrations can come from the road or engine and 
help protect essential parts from damage. These polymers must be extremely durable and 
very thermally stable for such applications.  
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 RB has also been utilized in other applications outside the spectrum of the 
automotive industry. RB is commonly used in chewing gum and pharmaceutical stoppers. 
RB and its copolymers have been used in DES as described earlier 39, 59, 82. Recently, 
there has been more focus on using RB as a viable biomaterial and improving its 
properties. The graft copolymers with PEO mentioned above have shown intriguing 
surface patterning but more interesting is the resistance to protein adsorption when higher 
weight percentages of PEO were attached 78. This was demonstrated by examining the 
fluorescent confocal microscopy images of the increasing amounts of PEO content. As 
seen in Figure 1.3.1e & f, which have 24 and 34 wt.% PEO, there is no fluorescence and 
this is consistent with no detectable protein adsorption.  
 
Figure 1.3.1 Fluorescence confocal microscopy images (543nm) of thin films (spin-cast 
at 20 mg/mL from CH2Cl2) following adsorption of a rhodamine-fibrinogen   conjugate. 
Images represent different wt.% of PEO grafted to the RB backbone; a) 2%, b) 4%, c) 
6%, d) 12%, e) 24% and f) 34% 78. 
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The use of PEO to eliminate protein adsorption on RB has been used in a laminate 
surface. In this work RB and epoxidized RB were spin cast, cross-linked using a new 
technique called Hyperthermal Hydrogen Induced Cross-Linking (HHIC) 83-85. The cross-
linked RB was then spin coated with PEO and cross-linked by HHIC. These surfaces 
were then subjected to fluorescently labeled fibrinogen to evaluate protein adsorption and 
cell studies were also performed. As seen in Figure 1.3.2a, RB supports well the growth 
of cells. Upon coating of RB with PEO a significant reduction in the number of cells was 
observed, a result attributed to their resistance to protein adsorption, which is thought to 
be the first step in the adhesion of cells to a surface.  Figure 1.3.2b illustrates the effect 
PEO has on RB surfaces in terms of decreased protein adsorption. Epoxidized-RB 
showed a substantial decrease in protein adsorption upon coating the RB surface with 
PEO 86.  
 
Figure 1.3.2  a) Evaluation of cell growth on surfaces. (a) RB, (b) epoxidized RB coated 
with PEO, (c) control surface of silane-functionalized PEO grafted on glass, (d) PEO-
coated silicon wafer following HHIC b) Relative fluorescence obtained by confocal 
microscopy corresponding to the adsorption of a fluorescently labeled fibrinogen on 
surfaces following HHIC. (a) RB, (b) epoxidized RB, (c) epoxidized RB coated with 
PEO, (d) PEO on clean silicon wafer, (e) control surface of silane functionalized PEO 
grafted on glass (0.01µg/cm2). Error bars represent the standard deviation of 10 
measurements on each of 3 samples 86. 
a)# b)#
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1.4 Motivation and Goals of Thesis  
With the synthetic knowledge for the preparation of the allylic alcohol derivative of 
RB 79, 87, it can be further modified to yield other materials that may improve certain 
properties. In the case of coronary stent coating applications, a polymer is required to 
adhere well to the metal. This reduces the chances of delamination of the coating, which 
has been reported in the commercial TAXUS stents 28, 29. This could lead to adverse 
events in vivo such as uncontrolled/altered drug release from the coating that could cause 
thrombosis. Lack of surface adhesion to metal surfaces is an issue in the case of RB due 
to its overall hydrophobicity and lack of polar groups. To tackle this issue, the 
introduction of more polar groups, specifically carboxylic acids may be useful. 
Carboxylic acid groups have been shown to exhibit increased surface adhesion to 
stainless steel surfaces 88. Also, the current commercial DES based on a SIBS coating has 
an initial burst release of the drug, paclitaxel followed by a long sustained release 58. The 
successful introduction of carboxylic acid groups can serve as a site for covalent 
immobilization of drugs via ester linkages. The covalent immobilization should eliminate 
the burst release 30, 31, creating a slower more controlled release of drug. Finally, these 
acid moieties on the PIB may serve to enhance adhesion to other materials than metal, 
such as bone 89, 90, which would be beneficial in applications such as bone cements 91.  
 The first goal of this thesis, described in Chapter 2, is to synthesize and study new 
PIB materials containing carboxylic acid functionalities. The starting material will be the 
allylic alcohol functionalized polymer (Scheme 1.3.5). The hydroxyl cannot undergo 
oxidation directly to the acid because it is a secondary alcohol. However, it should be 
possible to perform a ring opening of a cyclic anhydride to yield the acid product. There 
are literature examples of these cyclic anhydride ring openings with the use of 4-
dimethylaminopyridine (DMAP) as a catalyst 92-95. The initial allylic alcohol has an exo 
alkene present which could be used in thiol-ene “click” reaction 96, 97. It could also be 
possible to directly conjugate a thiol-acid, which would eliminate the double bond.  
These reactions will first be attempted with the RB containing 2.2% IP. If this does not 
yield a sufficient amount of acid functionality, then a higher 7.0% IP-RB can be utilized. 
Another possibility if this again does not provide a sufficient number of carboxylic acids 
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is to increase the carboxylic acid content significantly through a ring-opening 
polymerization (ROP) of a cyclic carbonate containing pendant carboxylic acids on the 
side chain, initiated by the hydroxyls along the RB backbone 98-100. Another alternative is 
to synthesize a poly(carboxylic acid) is the use of atom transfer radical polymerization 
(ATRP), which can polymerize many different monomers with varying functionality. 
ATRP has been completed on PIB but only reacting on the terminus of the polymer 101-
104. The resulting number of acid groups in this case would be equal to the number of 
monomer units polymerized. Thus, the first goal of this project will attempt to create acid 
functionalized RBs through the described methods.  
 The second goal of this thesis, described in Chapter 3, will be to explore the 
enhanced functionality of the carboxylic acid functionalized RB. The carboxylic 
functionality installed should allow for flexibility in the properties of the polymer. It is 
proposed that polar groups on the RB backbone will increase its surface adhesion to 
substrates especially stainless steel. Also it was shown that the introduction of an epoxide 
ring increased the compatibilization of a hydrophilic polymer like PEO 86 when 
producing laminates. Hence the allylic alcohol and acid functionality should further 
introduce compatibilization of PEO. Lastly, as described in Chapter 4, to address the 
issue of burst release inherent with DES, PTx will be conjugated to the RB backbone and 
be tested as drug delivery substrate. This thesis will be focused on the production of 
carboxylic acid moieties on the RB backbone and their potential applications. 
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Chapter 2  
2 Synthesis of Acid functionalized Butyl Rubber 
2.1 Introduction 
Butyl Rubber (RB) is a synthetic elastomer, which is used in many high 
performance applications due to its many attractive properties. These properties include 
water/gas impermeability, chemical stability, high elasticity and biocompatibility. 
Commercial RB is a co-polymer of isobutylene with small amounts of isoprene (IP). RB 
and its co-polymers are important components in many commercial products such as 
innerliners for automobile tires, sporting equipment, sealants and even chewing gum. One 
property of RB that is currently being investigated further is its biocompatibility. This is 
due to the growth of the aging populations with a growing demand for products to 
enhance life expectancy and quality.  
There has been some recent research in RB-based materials that are highly 
promising for a number of biomedical applications 1-3. A prime example is 
polyisobutylene-co-polystyrene (SIBS) triblock copolymers, which are currently being 
used for drug eluting coatings on TAXUS® vascular stents. Boston Scientific (U.S.A.) 
has commercialized this technology 1. This class of polymers has also been investigated 
as synthetic aortic valves 4 and as shunts for glaucoma 5. However, even the 
commercialized polymers have exhibited problems when integrated into implants. For 
example, SIBS was investigated as an implant in the urinary tract but there was 
significant attachment of uropathegenic species such as E. coli 67 6. Also, in the stent 
application there was coating delamination in vivo 7, 8. This indicates that the adhesion of 
SIBS polymers to the metal should be strengthened. The other major issue identified is a 
burst-release of the physically encapsulated drug from the laminate surface 9, 10, this 
causes a decrease in the life of the stent. There is a need for new materials and chemical 
synthesis to provide functionalized RB’s that will be better suited for medical 
applications. With the above issues in mind, it was proposed that the installation of 
carboxylic acid moieties on the RB backbone may reduce or eliminate these issues. Acid 
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groups have shown increased surface adhesion to stainless steel and other substrates in 
certain applications 11-13. Also, the acid group can act as a functional handle to covalently 
link a drug to the polymer reducing the burst release.  
The target product of an acid functionalized RB should be scalable, cheap and 
reliable for industrial purposes. Cyclic anhydrides have been known to ring open upon 
attack from alcohols 14-17. As shown in Scheme 2.1.1, upon treatment of RB (2.1) with m-
chloroperoxybenzoic acid (m-CPBA), an epoxide functionalized RB (2.2) is yielded 18, 19. 
The epoxide can then be treated with aqueous hydrochloric acid to provide an allylic 
alcohol functionalized polymer 2.3  20. The allylic alcohol serves as a perfect substrate for 
cyclic anhydride ring opening to yield the target carboxylic acid products. This avenue 
fills the desired criteria for a potential industrial application. The reaction utilizes 
inexpensive cyclic anhydrides and only requires three steps to yield the desired product 
(Scheme 2.1.1). This chemistry has been recently utilized to functionalize hydroxlyated 
poly(ethylene glycol) and then this acid was used as a functional handle to covalently 
attach a drug 21.   
 
Scheme 2.1.1 Proposed general route towards carboxylic acid functionalized butyl 
rubber.  
Another potential way of synthesizing carboxylic acid functionalized RB would 
be utilizing 2.3 and performing a thiol-ene click reaction (Scheme 2.1.2). Thiol-ene 
chemistry, the reaction of a thiol with an alkene moiety under free radical conditions, has 
proven to be an effective synthetic tool in small molecule and polymer chemistry in 
recent years 22, 23. It can provide numerous advantages including high chemoselectivity, 
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tolerance to oxygen, water, and a wide range of functional groups, relatively simple 
purification, high rates of reaction and quantitative conversion. These advantages, 
combined with the presence of double bond moieties throughout the backbone of butyl 
rubber make this reaction attractive for the introduction of various functionalities to RB. 
Along with the introduction of functional groups, this reaction should also result in the 
conversion of unsaturated to saturated moieties, potentially improving the chemical, 
oxidative, and biological stability of the butyl rubber backbone. Thus far, there are a very 
limited number of examples involving the use of thiol-ene chemistry with 
polyisobutylene derivatives 24-26; these examples have much lower molecular weights 
than the commercialized RBs. The polymers reported involved the modification of 
terminal exo-alkene units of telechelic RB (a polymer in which both ends contain the 
same functionality) by Storey and coworkers.  
 
 
Scheme 2.1.2 Proposed reaction of butyl rubber derivative 2.3 and TGAc in the presence 
of a photochemical initiator. 
Another possibility is to introduce multiple carboxylic acids on the backbone by 
polymerization from the hydroxyl groups on the modified RB backbone. This would 
allow for tuning of surface adhesion as well as drug loading by tuning the length of the 
poly(carboxylic acid) chains. There are several potential avenues to produce a 
poly(carboxylic acid) functionalized RB. Ring-opening polymerizations (ROP) of cyclic 
carbonates have been performed from alcohol initiators.  Hedrick et al. have 
demonstrated polymerization of cyclic carbonates from simple alcohols to yield various 
co-polymers 27-29. The monomers have flexibility in terms of the types of functional 
groups that can be incorporated. To produce an acid functionalized RB, the monomer was 
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protected, then deprotected after polymerization. The proposed polymerization is shown 
in Scheme 2.1.3.  
  
Scheme 2.1.3 Proposed reaction of butyl rubber derivative 2.3 to produce a graft 
copolymer containing protected carboxylic acids via ring-opening polymerization of a 
cyclic carbonate.  
 Atom-Transfer Radical Polymerization (ATRP) is an alternative approach to yield 
a poly(carboxylic acid) functionalized RB.  Previous work has involved the use of 
standard ATRP conditions to polymerize various methacrylate/acrylate monomers to 
produce relatively low molecular weight copolymers of PIB 30-33. They successfully 
incorporated an ATRP initiator to PIB by coupling α-bromoisobutyryl bromide to the 
terminus of hydroxyl functionalized PIB under basic conditions. For the current work 
polymer 2.3a is proposed as a suitable substrate for the production of the required 
bromide initiator followed by ATRP (Scheme 2.1.4). Tert-butyl methacrylate is proposed 
as the monomer due to the ease of its polymerization, deprotection and its commercial 
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availability 30. 
 
Scheme 2.1.4 Proposed reaction of butyl rubber derivative 2.3a to form an ATRP 
initiator, followed by subsequent synthesis of a RB-co-poly(tert-butyl methacrylate) and 
its deprotection to yield the target RB-co-poly(methacrylic acid).   
 This chapter will describe the investigation of several approaches to the synthesis 
of carboxylic acid functionalized RB. The ring opening of cyclic anhydrides, thiol-ene 
coupling, the ring opening polymerization, and ATRP of protected poly(carboxylic acids) 
from the hydroxyl functionalized butyl rubber derivative 2.3a was studied and the 
products were characterized chemically by techniques including NMR, IR, SEC, TGA 
and DSC. 
2.2 Results and Discussion  
2.2.1 Cyclic Anhydride Ring-Opening 
The study began by evaluating the reaction of RB derivative 2.3a/b with various 
cyclic anhydrides that are commercially available and inexpensive (Table 2.2.1). The 
anhydrides all differed in either ring size, degrees of unsaturation or electronics; this gave 
a suitable cross-section of the anhydrides that would be most advantageous for ring 
opening.  
Table 2.2.1 A summary of the cyclic anhydrides used to create carboxylic acid modified 
RB. Each anhydride has different electronics, ring sizes and degrees of saturation. 
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Anhydride	   Target	  Product	   Equivalents	   %	  Conversion	  
	  
2.4a/b	   10-­‐20	   100%	  
	  
2.5	   20	   ~50%	  
	  
2.6	   20	   5-­‐6%	  
	  
2.7	   20	   NA	  
 Using 1H NMR spectroscopy, the conversion was calculated relative to the initial 
alcohol functionalized polymer 2.3a/b and differences in reactivity were observed (Table 
2.2.1). The six-membered anhydrides worked with the highest conversions, diglycolic 
anhydride having complete conversion to the corresponding acid. The 1H NMR spectrum 
after reaction of 2.3a/b with diglycolic anhydride (2.4) showed no starting allylic alcohol 
(Figure 2.2.1).  The structure of the expected product was also supported by IR 
spectroscopy (Figure 2.2.2), with the appearance of two peaks in the carbonyl region at 
1728 and 1748 cm-1. These peaks correspond to the acid as well as the ester. In contrast, 
the five-membered anhydrides worked only to a small extent, if at all, to yield the desired 
carboxylic acid products. Succinic anhydride (2.6) showed minimal conversion whereas 
maleic anhydride (2.7) reacted rapidly to yield an insoluble product 34. These results were 
rationalized by the ring strain within the six-membered anhydride causing them to be 
more reactive than the five-membered counterparts. Diglycolic anhydride went to 
completion (2.4) and was more reactive than glutaric anhydride (2.5) due to the electron 
withdrawing effects of the extra oxygen.  The scalability was also tested using diglycolic 
anhydride. These reactions were completed on two different isoprene contents a-2.2 & b-
7.0%, which represents 2.4a/b respectively. The reaction can be successfully synthesized 
O
OO O
O OO
OO O
OO O
34 
 
in a greater than 10 g scale. This was an encouraging sign for testing in larger scale 
reactors. 
 
Figure 2.2.1 1H NMR spectra of a) polymer 2.3a; b) after reacting with to form 2.4a 
(CDCl3, 400 MHz).   
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Figure 2.2.2 IR trace of acid modified RB 2.4a, the acid confirmed with the appearance 
of two carbonyl peaks at 1728 and 1748 cm-1. 
2.2.2 Thiol-ene “Click” Chemistry 
Initial attempts to directly functionalize polymer 2.1 via thiol-ene chemistry did 
not lead to any detectable conversion. This is consistent with the lower reactivity of endo 
double bonds in the thiol-ene chemistry and the low accessibility of these bonds along the 
backbone of this high molecular weight polymer. The allylic alcohol 2.3 has an exo-
alkene that would be more accessible for thiol-ene chemistries. Storey and coworkers 
were able to successfully perform thiol-ene chemistry on the terminal exo-alkene of 
telechelic RB 22, 23; hence 2.3 might be more amenable to functionalization by thiol-ene 
chemistry. Using the reaction conditions previously reported for telechelic RB as a 
starting point 24, a number of reaction conditions were explored. Storey and coworkers 
used 2,2-dimethoxy-2-phenyl acetophenone (DMPA) as the photo-initiator and the 
reactions were performed with photochemical irradiation in CHCl3. Following literature 
precedent, reactions were carried out under inert conditions, degassing for a minimum of 
15 minutes to ensure that no oxygen is present.  We selected thioglycolic acid (TGAc) as 
our thiol in initial work in order to introduce carboxylic acid moieties.  
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Table 2.2.2 summarizes the results of reaction attempts that involved different 
equivalents of thiols (relative to the double bond on the rubber) and different irradiation 
times. First, to ensure the stability of polymer 2.3 under the reaction conditions, control 
experiments were performed. Polymer 2.3 was exposed for various increments of time to 
UV light and it was observed that it was stable beyond one hour of irradiation. Next, the 
photoinitiator DMPA was added and the mixture was exposed for similar time periods. 
Again similar stability was observed. In contrast, upon the addition of 3 equivalents of 
TGAc to the reaction mixture and exposure to UV irradiation in the presence of DMPA 
some significant changes were observed in the 1H NMR spectrum. Figure 2.2.3 shows the 
spectrum of the starting polymer 2.3. As shown in Figure 2.2.3, after 10 minutes of 
irradiation, new peaks were observed in the NMR spectrum, though it was difficult to 
assign these peaks entirely to the expected product, suggesting the presence of 
byproducts. After 60 min of irradiation, the starting material peaks in the NMR spectrum 
had almost entirely disappeared but again the spectrum was messy and it appeared that a 
number of byproducts were generated in the reaction.  
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Table 2.2.2 Reaction conditions and results for the photoinitiated thiol-ene reaction 
between polymer 2.3 and TGAc. 
Thiol	   Initiator	  
(Y/N)	  
UV	  
Exposure	  
(min.)	  
Result	  
None	   N	   60	   No	  detectable	  changes	  in	  
the	  NMR	  spectrum	  
None	   Y	   60	   No	  detectable	  changes	  in	  
the	  NMR	  spectrum	  
TGAc	  (3	  equiv.)	   Y	   10	   Partial	  conversion	  with	  
byproduct	  generation	  
TGAc	  (3	  equiv.)	   Y	   60	   Near	  complete	  conversion	  
with	  byproduct	  generation	  
Dodecanethiol	  
(5	  equiv.)	  
Y	   60	   Near	  complete	  conversion	  
but	  possible	  byproduct	  
generation	  and	  difficulties	  
removing	  excess	  thiol	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Figure 2.2.3 1H NMR spectra of a) polymer 2.3a; b) reaction product after 10 minutes of 
UV irradiation; c) reaction product after 1 hour of irradiation (3 equiv. of TGAc, DMPA 
photoinitiator). (CDCl3, 400 MHz) 
At this stage it was proposed that byproducts might have resulted from the 
presence of the acidic carboxylic acid moiety on TGAc. Thus, the reaction was repeated 
with 1-dodecanethiol. The NMR spectrum (Appendix E) suggested that at least partial 
conversion to the product may have occurred, but again the reaction was not clean and 
was not complete. Furthermore, it was difficult to separate the excess 1-dodecanethiol 
from the product rubber.  
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2.2.3 Synthesis of Poly(carboxylic acid) Functionalized RB 
This study began by using polymer 2.3 as the initiator and the benzyl protected 
cyclic carbonate as the monomer 27, 28, 35. The cyclic carbonate was copolymerized with ε-
caprolactone as per literature protocol 36. The polymerization was relatively successful 
but the major issue was removal of the benzyl-protecting group via hydrogenation.  Upon 
many attempts with various different conditions and monomer modification this 
polymerization technique was deemed not suitable and was abandoned.  
Controlled radical polymerization techniques have been abundant in the literature 
as a means of producing functional co-polymers. The polymerization technique chosen 
was atom transfer radical polymerization (ATRP). This technique utilizes a copper/ligand 
system as a catalyst for polymerization.  This technique was also chosen due to the easy 
installation of a bromo-initiator required for polymerization 30, 32, 33, 37. Polymer 2.3 was 
reacted with α-bromoisobutyryl bromide in the presence of triethylamine to yield the 
required bromo-initiator with a simple one step reaction. The 1H NMR validated that the 
reaction went to completion yielding initiator 2.8 (Figure 2.2.4a). 
 The polymerization conditions followed literature precedent using copper  
bromide (CuBr) with the ligand 1,1,4,7,10,10- hexamethyltriethylenetetramine 
(HMTETA) as the catalyst 30. The monomer selected was tert-butyl methacrylate (tBMA) 
due to the ease of removal of the tert-butyl group to yield the final grafted 
poly(carboxylic acid).  
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Figure 2.2.4 1H NMR spectra of a) polymer 2.8 the bromo-initiator; b) after 
polymerization with tBMA 2.9 (CDCl3, 400 MHz).   
 The polymerization was completed with tBMA and a small library of copolymers 
was prepared by tuning the degree of polymerization of tBMA (Table 2.2.3). The 1H 
NMR spectrum (Figure 2.2.4b) shows conversion from 2.8 to the graft copolymer with 
broad polymeric peaks belonging to poly(tert-butyl methacrylate). It is interesting to note 
that at longer grafted chain lengths the polymer acted more like the arms than the core. 
Thus, the polymer became soluble in non-conventional solvents of RB such as acetone. 
Upon shortening the arms, the copolymer was observed to behave more like RB. This 
made purification very challenging for the longer chain polymers, so homopolymer 
poly(tert-butyl methacrylate) remained in the samples that could not be removed by 
conventional methods (Figure 2.2.5). The change in Mn can be seen in Table 2.2.3 and 
the SEC traces indicated the issue of homopolymerization. The grafting of shorter chains 
was investigated to see if it would eliminate the issue of purification. Upon reacting 2.8 
with 15-50 equivalents of monomer (2.9/2.10), it was observed that there was no longer a 
side peak in the SEC trace. The resulting copolymer acted more like standard RB, 
allowing it to be precipitated in acetone. Thermogravimetric analysis (TGA) was then 
performed on several of the copolymers synthesized. The tert-butyl group begins 
degrading at ~210 °C which is prior to the degradation of the polymer backbone. These 
values allow for degree of polymerization to be calculated and these results can be seen 
in Table 2.2.4. 
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 Table 2.2.3 Molecular weight data collected using SEC for the various equivalents of 
tert-butyl methacrylate co-polymers polymerized from initiator 2.8. Mw and Mn are given 
relative to polystyrene standards. 
	   Equivalents	   Mw	  (g/mol)	   Mn	  (g/mol)	   PDI	  
2.8	   0	   397,000	   139,900	   2.8	  
2.9	   15	   195,000	   86,500	   2.3	  
2.10	   50	   285,000	   96,000	   3.0	  
2.11	   100	   566,000	   185,000	   3.6	  
2.12	   300	   817,000	   225,000	   3.7	  
Table 2.2.4 Data collected from TGA analysis and converted to degree of 
polymerization. 
	   Equivalents	  
Wt.%	  tert	  butyl	  
group	  
Degree	  of	  
Polymerization	  
2.9	   15	   9.0	   5	  
2.10	   50	   19	   17	  
2.11	   100	   33	   89	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Figure 2.2.5 SEC traces of the co-polymers created with varying equivalents of tert-butyl 
methacrylate.  
 Deprotection of copolymer 2.9 was then investigated to yield the target 
poly(carboxylic acid) functionalized RB. In the literature there are many routes to 
deprotection. The three most common are 1) thermolysis 32, 33 2) heating in the presence 
of hydrochloric acid 30 & 3) use of trifluoroacetic acid (TFA) at room temperature 37. We 
attempted thermolysis first due to its simplicity and the avoidance of strong acids. Upon 
exposure in the vacuum oven at 150 °C and 30 mbar it was observed that deprotection 
was not close to completion. This was rationalized by RB’s gas impermeability, so the 
focus was shifted to the use of TFA as a means of deprotection. First a control reaction 
was done to demonstrate the stability of RB to TFA treatment. After stirring RB in TFA 
for 2 h, an NMR spectrum was obtained which showed no changes relative to the starting 
polymer. SEC also showed no change in the polymer molecular weight. The copolymer 
was very soluble in dichloromethane (CH2Cl2) and upon adding TFA the polymer did not 
precipitate, meaning the reaction should be viable. However, after two hours the polymer 
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precipitated out of the CH2Cl2 and aggregated. Once the TFA was removed the polymer 
was not soluble in any common NMR solvents therefore, deprotection was followed 
using IR spectroscopy 30. The IR spectra suggested the emergence of a new peak 
corresponding to the carboxylic acid moiety at ~1700 cm-1. Though it was difficult from 
the spectrum to determine whether complete deprotection was achieved, certainly a 
significant portion of the carboxylic acid moieties appeared to be unmasked (Figure 
2.2.6).  
 
Figure 2.2.6 IR traces of copolymer 2.9 & deprotected copolymer 2.13, the carbonyl 
region to show a broadening of the carbonyl stretch, suggestive of the emergence of a 
new peak corresponding to the carboxylic acid at 1701 cm-1. 
2.3 Conclusions 
Several methods of producing carboxylic acid functionalized RBs were 
investigated. Installation of the acid moieties on the backbone was successfully 
completed using ring opening of a cyclic anhydride and using ATRP polymerization 
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conditions. Diglycolic anhydride was ring opened to yield a full conversion to the 
carboxylic acid product. Also, polymerization of tert-butyl methacrylate under ATRP 
conditions provided a copolymer that could be deprotected using TFA to yield a 
poly(carboxylic acid). Other investigated approaches yielded no straightforward route to 
the desired product. Thiol-ene chemistry had too many side reactions while ring-opening 
polymerization was successful but deprotection of the benzyl-protecting group was not 
possible.  
2.4 Experimental  
General  
LANXESS Butyl 402 (Mw = 4.69 × 105 g/mol, PDI = 2.4) and butyl rubber containing 7 
mol% (Mw = 1.05 × 106 g/mol, PDI = 3.3) isoprene were provided by LANXESS Inc. 
Silicon wafers were purchased from University Wafer (Boston, MA). Solvents were 
purchased from Caledon and all other chemicals were purchased from Sigma-Aldrich and 
were used without further purification unless otherwise noted. Dry toluene was obtained 
from a solvent purification system. 1H NMR spectra were obtained in CDCl3 at 400 MHz. 
NMR chemical shifts (δ) are reported in ppm and are calibrated against residual solvent 
signals of CDCl3 (δ 7.26). Infrared spectra were obtained as films from CH2Cl2 on NaCl 
plates using a Bruker Tensor 27 instrument. Differential scanning calorimetry (DSC) and 
thermal gravimetric analysis (TGA) was performed on a Mettler Toledo DSC 822e at a 
heating rate of 10 °C/min from -120 to +150 °C. 
Synthesis of polymer 2.4a 
RB derivative 2.3a (10 g, 3.9 mmol of –OH) was dissolved in 350 mL of toluene. The 
solution was heated to 70 °C, then 20 equivalents of triethylamine (10.9 mL, 78 mmol) 
was added followed by 2 equivalents of 4-(dimethylamino)pyridine (0.99 g, 7.8 mmol). A 
solution of diglycolic anhydride (10 equivalents, 4.5 g, 39 mmol) dissolved in toluene 
was then added via syringe and the reaction mixture was stirred at 70 °C overnight. The 
product was then washed with distilled water and 6 M HCl twice, followed by 
concentration under reduced pressure. The product was further purified by precipitation 
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(2:1 Acetone/Toluene) and then dried under vacuum. Conversion = 100% Yield = 90% 
1H NMR (400 MHz, CDCl3) 5.29 (br s, 1H), 5.12 (s, 1H), 4.95 (s,1H), 4.20-4.40 (m, 4H), 
1.42 (s, 145H), 1.12 (s, 431H). SEC: Mw = 308900 g/mol, PDI = 2.52. IR: 1230, 1365. 
1390, 1475, 1733, 1758, 2974 cm-1. Tg= -61 °C  
Synthesis of polymer 2.4b 
RB derivative 2.2b (10 g, 12.1 mmol of epoxide) was dissolved in 350 mL toluene. The 
solution was treated with one equivalent HCl (1.0 mL,  12.1 mmol) and allowed to react 
at room temperature for 1 hour. Due to solubility issues 3b was not isolated. Instead the 
HCl was neutralized with Sodium Carbonate and then dried with MgSO4. The mixture 
was then centrifuged and 3 was decanted from the MgSO4. The solution was heated to 70 
°C, then 20 equivalents of triethylamine (33.7 mL, 242 mmol) was added followed by 2 
equivalents of 4-(dimethylamino)pyridine (3.1 g,  24.2 mmol). A solution of diglycolic 
anhydride (10 equivalents, 14.0 g, 121 mmol) dissolved in toluene was then added via 
syringe and the reaction mixture was stirred at 70 °C overnight. The product was then 
washed with distilled water and 6 M HCl twice, followed by concentration under reduced 
pressure. The product was further purified by precipitation (2:1 Acetone/Toluene) and 
then dried under vacuum. Conversion = 100% Yield = 90% 1H NMR (400 MHz, CDCl3) 
5.29 (br s, 1H), 5.12 (s, 1H), 4.95 (s,1H), 4.20-4.40 (m, 4H), 1.42 (s, 69H), 1.12 (s, 
209H). IR: 1230, 1365. 1390, 1475, 1733, 1758, 2974 cm-1. Tg= -53 °C  
Ring opening polymerization from polymer 2.3a 
Polymer 2.3a was dissolved in dry toluene under nitrogen. Bn-MTC was dissolved in dry 
toluene and was added to the solution followed by ε-caprolactone. The mixture was 
heated to 70º C. The catalyst 1,5,7 triazabicyclo[4,4,0] dec-5-ene was added and the 
solution was allowed to react overnight. The resultant mixture was then washed twice 
with water and precipitated using 2:1 Acetone/Toluene. Polymer was dried under 
vacuum. 1H NMR (400 MHz, CDCl3): 7.36 (Bn-MTC br m, 5H), 5.24 (s, 1H), 5.12-5.16 
(Bn-MTC s, 2H), 4.90 (s, 1H), 4.24 (br m, 4H), 4.06-4.11 (CL, m, 8H) 2.31 (CL m, 8H), 
1.42 (CH2, 143H), 1.12 (s, CH3, 424H). SEC: Mw = 489000 g/mol, PDI = 1.73. 
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Synthesis of polymer 2.8    
Butyl rubber derivative 2.3 (10 g, 3.9 mmol of –OH) was dissolved in 350 mL of toluene. 
The solution was heated to 70 °C, then 14 equivalents of triethylamine (7.60 mL, 54.6 
mmol) was added followed by 14 equivalents of 2-bromoisobutyrl bromide (6.95 mL, 
54.6 mmol). The solution was stirred overnight at 70 °C, then the reaction mixture was 
washed with distilled water three times, then concentrated under reduced pressure. The 
product was further purified by precipitation (2:1 Acetone/Toluene) and then dried under 
vacuum. Conversion = 100% Yield = 80% 1H NMR (400 MHz, CDCl3) 5.22 (s, 1H), 
5.19 (br s, 1H), 4.92 (s, 1H), 1.97 (s, 6H), 1.42 (s, 290H), 1.12 (s, 913H).  SEC: Mw = 
396900 g/mol, PDI = 2.84. IR: 1232, 1367, 1390, 1479, 1736, 2977 cm-1. 
 
Synthesis of polymer 2.9 
In a predried Schlenk tube under a nitrogen atmosphere at room temperature were placed 
1 eq. CuBr (0.13 mmol, 0.187 g), a stirring bar, 2 eq. of the ligand 1,1,4,7,10,10- 
hexamethyltriethylenetetramine (HMTETA) (0.26 mmol, 0.071 mL), 15 eq. of 
deoxygenated tert-butyl methacrylate (1.95 mmol, 0.316 mL), and toluene. The tube was 
tightly sealed with a rubber septum and degassed by three freeze–pump–thaw cycles. 
Right after the addition of 2.8 (0.13 mmol, 0.356 g) initiator by a syringe, the tube was 
immersed in a thermostated oil bath maintained at 70 °C. After twelve hours the solution 
was exposed to the atmosphere and concentrated using rotary evaporation. The crude 
mixture was then precipitated in methanol and washed with water. 1H NMR (400 MHz, 
CDCl3) 5.16 (br s, 2H), 4.92 (s, 1H), 1.82 (tBMA, brs, 22.49H), 1.44 (tBMA, brs, 
99.75H) 1.42 (s, 290H), 1.12 (s, 913H), 1.05 (tBMA, m, 58.13H), ).  SEC: Mw = 195000 
g/mol, PDI = 2.26. IR: 1253, 1367, 1392, 1483, 1728, 2981 cm-1.  
Synthesis of polymer 2.13 
The poly tert-butyl methacrylate- RB co-polymer was dissolved in CH2Cl2 in a round 
bottom with a magnetic stir-bar. Upon dissolution of the polymer a 10-molar excess TFA 
was added to the solution. The reaction was then left for twenty-four hours at  25 °C. The 
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solvent and TFA was removed via evaporation, the polymer was re-dissolved and 
evaporated for three cycles. IR: 1203, 1280, 1390, 1450, 1488, 1701, 2603, 2972, 3471 
cm-1. 
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Chapter 3  
3 Improvements to the Physical Properties of Butyl 
Rubber  
Contribution Statement: Surface adhesion testing was completed in collaboration with 
LANXESS Inc. and was performed by Brianna Binder. Dr. Heng-Yong Nie at Surface 
Science Western assisted with AFM training and imaging  
3.1 Introduction  
Butyl Rubber (RB) is a synthetic elastomer that contains many attractive 
properties such as gas/water impermeability, chemical stability, excellent mechanical 
properties and biocompatibility 1, 2 . With all of these attributes there are still some 
limitations. One limitation is the ability to create homogeneous coatings of 
hydrophilic/polar materials or polymers such as poly(ethylene oxide) (PEO) on a RB 
surface 3 . Surface homogeneity is crucial to expand the applications of RB to biomedical 
devices, especially in-vivo. This incompatibility is due to the very hydrophobic nature of 
RB and is evidenced by a relatively high contact angle of ~90°. This creates a surface that 
is difficult to coat due to the incompatibility of polar materials with a non-polar surface. 
Such incompatibility hinders the wettability of the polar material and thus yields a 
partially coated surface 4, 5 . The resultant surfaces are not appropriate for high-end 
applications like biomaterials where a high degree of surface uniformity is needed. Thus, 
there is a need to investigate potential compatibilization approaches to create much more 
homogeneous surfaces.  
 The other inherent problem with RB as a biomaterial is delamination of RB 
coatings from substrates such as stainless steel 6, 7 . This again limits the use of such 
polymers in bio-medical applications because once delamination occurs it can cause 
major implications in vivo and is of particular relevance to RB-based copolymers used 
clinically as coatings on drug-eluting stents 8 . The surface adhesion of RB to metallic 
substrates should ideally be improved. Both of these surface compatibility issues can be 
addressed by modification of the polymer backbone and introducing different 
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functionalities along the RB backbone. Recently, as shown in Scheme 3.1.1, 
modifications have been made along the RB backbone that can yield multiple oxygen-
containing functionalities including an epoxide, an alcohol and a carboxylic acid 9 . In 
previous work it was noted that there was increased compatibilization between butyl 
rubber and polar polymers when an oxygen-containing butyl rubber derivative was used 
as the substrate 10 . For example, it was found that it was possible to prepare uniform, 
cross-linked films of PEO on epoxidized butyl rubber (3.2a), but not on butyl rubber 
itself (3.1a). However, the other oxygenated butyl rubber derivatives such as 3.3a and 
3.4a were not previously investigated. It was also anticipated that such oxygenated butyl 
rubber derivatives might provide enhanced adhesion to metal substrates 11-13 , a property 
that could significantly enhance their performance in applications such as stent coatings.  
  
Scheme 3.1.1 The oxygenated RBs synthesized from commercially available RB (3.1); 
epoxide (3.2), alcohol (3.3) and carboxylic acid (3.4).  
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 In this chapter, the performance of oxygenated butyl rubber derivatives including 
3.2a, 3.3a, and 3.4a as compatibilizing layers to enable the coating of butyl rubber with 
more hydrophilic polymers such as PEO is described. The surfaces are characterized by 
static contact angle measurements and atomic force microscopy (AFM). In addition, the 
adhesion properties of these polymers (3.2a/b, 3.3a/b, and 3.4a/b)  to stainless steel are 
also described. 
3.2 Results and Discussion  
3.2.1 The application of oxygenated RBs as compatibilizing layers  
The previously reported approach for investigating the compatibilization properties of 
epoxidized butyl rubber was used for the current work. A silicon wafer was selected as 
the underlying substrate due to its flat nature. A cleaned 1 cm x 1 cm silicon wafer was 
spin coated with 3.1a (5 mg/mL in toluene) (Figure 3.2.1). In order to prevent dissolution 
of each polymer layer during the deposition of subsequent layers, each layer was cross-
linked by a method termed hyperthermal hydrogen induced cross-linking (HHIC). This is 
an alternative to conventional plasma treatments 14-17 . Briefly, when a lightweight 
projectile such as an atom or molecule, possessing elevated kinetic energy collides with 
the atoms of organic molecules on a substrate, there is a transfer of kinetic energy. The 
projectile is generally H+ 15, 16  or H2 14 . It has been demonstrated through molecular 
dynamics simulations and experiments, that the collision is only effective if it collides 
with a hydrogen atom of the organic molecule as opposed to a heavier atom such as 
carbon or oxygen. This mechanism depends on mass-dependent kinematic energy 
transfer, which is readily understood when it is simplified to the framework of hard-
sphere collision theory. A hydrogen projectile can transfer 100% of its kinetic energy to a 
hydrogen target but the maximum drops to 28% when the target is carbon. This allows 
for selective breaking of C-H bonds without breaking other bonds. Thus, HHIC is 
functional group tolerant, which is not the case for most traditional plasma techniques 18, 
19 . Once radicals are produced on the surface molecules, they can recombine and form a 
cross-linked layer, thus providing an elegant means of preparing chemically grafted, 
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cross-linked surfaces (Figure 3.2.2). There are limited examples of using HHIC but all 
have thus far demonstrated functional group tolerance 3, 20, 21 . 
 
 
Figure 3.2.1 Thin film preparation of RB/PEO films using spin casting and HHIC. 
 
Figure 3.2.2 Visual depiction how molecules form radicals and recombine to form cross-
linked films via HHIC.   
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 Following cross-linking by HHIC, the butyl rubber layer was characterized by 
AFM to measure film thickness and surface uniformity, and contact angle measurements 
were performed. It was found that upon coating RB onto the silicon substrate, a very 
homogenous film was obtained. The surface was visualized using AFM, as shown in 
Figure 3.2.3a and AFM was also used to quantify the average surface roughness, which 
was 1.5 nm. The oxygenated butyl rubbers 3.2a, 3.3a, or 3.4a, were then deposited on top 
of the butyl rubber layer by spin coating and cross-linked by HHIC. As shown in Table 
3.2.1, it was found that the thickness increased upon coating the oxygenated RBs, which 
was expected. Also seen was the same surface roughness as the RB under layer, as well 
as similar contact angles. Upon visualization with AFM it was seen that a homogenous 
film was obtained for these laminates.  
 
Figure 3.2.3 a) AFM image (topography) of 3.1a b) AFM image of 3.2a spin coated on 
3.1a. AFM images correspond to a 5 µm x 5 µm area.  
 
 
 
 
 
a) b) 
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Table 3.2.1 Tabulated data of static contact angles, film thickness and roughness from 
AFM for the laminates of 3.2a, 3.3a, 3.4a coated on 3.1a. 
Sample	   Film	  Thickness	  (nm)	  
Film	  Roughness	  
(nm)	  
Static	  CA(°)	  
Butyl	  402	  3.1a	   28	   2	   91.5	  ±	  1	  
Epoxidized	  Butyl	  
3.2a	  on	  3.1a	  
43	   2	   87.7	  ±	  2	  
Hydroxyl	  
functionalized	  butyl	  
3.3a	  on	  3.1a	  
45	   2	   87.0	  ±	  0.4	  
Acid	  functionalized	  
butyl	  3.4a	  on	  3.1a	  
41	   2	   85.9	  ±	  3	  
 In order to investigate the capabilities of the various oxygenated butyl rubber 
derivatives to compatibilize butyl rubber towards more hydrophilic polymers, PEO was 
selected as the coating material. It was chosen due to its many desirable properties such 
as resistance to protein adsorption as well as its biocompatibility 22-26 . Hydrophobic 
elastomers like RB are known to strongly adsorb proteins 1, 3 , which limits their use in 
biomedical applications. PEO was spin coated from CH2Cl2 onto butyl rubber as well as 
the oxygenated rubber surfaces described above. Upon coating PEO on native butyl 
rubber (3.1a) it was found using AFM that the resulting layer was very non-uniform 
(Figure 3.2.4). In contrast, when 3.2a was coated prior to coating of PEO there was a 
remarkable difference in the surface homogeneity. This has been described previously 3  
but upon coating with 3.3a & 3.4a homogenous films were also obtained (Figure 3.2.4 b-
d). The laminate formed with 3.3a showed no improvement to surface roughness or static 
contact angles relative to 3.2a.  3.4a showed slight improvement in surface roughness and 
decreases in the contact angles, though the differences were not statistically significant 
(Table 3.2.2). It has been shown with 3.2a that the increased homogeneity of the PEO 
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film relative to that on unmodified butyl rubber translates into a substantial decrease in 
the amount of protein absorption 3 . Based on the results for 3.3a and 3.4a, it can also be 
inferred that such PEO coatings would resist the adsorption of proteins.  
 
Figure 3.2.4 a) AFM image (topography) of PEO coated on 3.1a b) AFM image of PEO 
spin coated on 3.2a c) AFM image of PEO spin coated on 3.3a d) AFM image of PEO 
spin coated on 3.4a. AFM images correspond to a 5 µm x 5 µm area. 
Table 3.2.2 Tabulated data of static contact angles, film thickness and roughness from 
AFM for the PEO coated onto RB samples. 
Sample	  
Film	  Thickness	  
(from	  AFM)	  (nm)	  
Film	  Roughness	  
(from	  AFM)	  (nm)	  
Static	  CA	  (°)	  
PEO	  on	  RB	  3.1a	   32	   18	   59	  ±	  1	  
PEO	  on	  Epoxidized	  
RB	  3.2a	  on	  3.1a	  
56	   5	   49	  ±	  3	  
PEO	  on	  Hydroxyl	  
functionalized	  RB	  
3.3a	  on	  3.1a	  
53	   6	   51	  ±	  3	  
Acid	  functionalized	  
RB	  3.4a	  on	  3.1a	  
53	   5	   48	  ±	  3	  
a) b) c) d) 
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3.2.2 Measurement of the adhesion of RB derivatives to a 
stainless steel substrate 
The synthesis of polymers 3.2a/b, 3.3a/b, and 3.4a/b was performed on a 5-10 g 
scale as described in Chapter 2. Surface adhesion or stickiness was determined by the 
amount of force required to remove the sample from the substrate. In the current work, a 
stainless steel substrate was selected due to the interest in the adhesion of RB copolymers 
to stainless steel stents 27 . The experiments were completed in collaboration with 
LANXESS Inc. by measuring the force required to separate the material and the 
substrate. The test specimens consisted of 6.4 X 50.8 mm reinforced strips with a 
thickness between 0.5 and 3.3 mm. They were produced by pressing the material in a 
square mold at 100 °C for five minutes between Mylar and Teflon. From these sheets the 
samples were cut and tested. The test specimens were placed in the apparatus at right 
angles to each other, which defined the area of contact. Once the two specimens came 
into contact with each other, force was then applied in the opposite direction, and the 
amount of energy required to separate the two plates was measured. This energy was 
defined as the surface adhesion.  
 The adhesion of the commercially available RB 3.1a/b is well known and the 
various oxygenated RBs (3.2a/b, 3.3a/b, 3.4a/b) were tested and compared to 3.1a/b. All 
of the oxygenated RBs showed significant improvements in adhesion to the stainless steel 
substrate. The largest improvement in adhesion was seen with 3.4a, which took 32.8 ± 
1.3 psi to separate (Table 3.2.3.)  This can be attributed to the installation of the acidic 
group on the backbone. It was believed that increasing the amount of IP from 2.2 to 7.0% 
would increase the adhesion accordingly in 3.4b versus 3.4a due to the increase in acidic 
groups, but this was not observed. This was attributed to the material being highly 
ionomeric in nature, which limited its flow. The reduction in flow made it exceedingly 
difficult to process the sample for this test. Hence the value observed for 3.4b was not 
indicative of what the adhesion should be for such a material. These values can also be 
compared to previously reported values for cationic ionomers of RB such as those 
containing pendant phosphonium groups 28 . These polymers provided a remarkable 
increase in the amount of adhesion to stainless steel; they observed an increase to 30.3 psi 
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with an IP content of 6.5% 29 . The results for the oxygenated butyl rubber derivatives are 
very similar to these, making them very promising materials to eliminate the issue of 
delamination and provide better coating adhesion to stainless steel.  
Table 3.2.3 Surface adhesion data obtained on the Tel-Tak system with a stainless steel 
substrate for the different oxygenated RBs.  
Variations	  of	  RB	  
Force	  to	  separate	  (psi)	  
2.2%	   7%	  
	  
14.6	  ±	  0.3	   12.1	  ±	  0.2	  
	  
22.2	  ±	  2.2	   25.2	  ±	  1.6	  
	  
29.6	  ±	  0.6	   20.5	  ±	  2.1	  
	  
32.8	  ±	  1.3	   28.3	  ±	  2.7	  
3.3 Conclusions  
Compatibilization of polar materials on butyl rubber surfaces was improved by 
using oxygenated butyl rubber derivatives as compatibilizing layers. To demonstrate this, 
n m
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n m
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PEO was coated on the compatibilizer layers providing more uniform coatings, as 
measured by AFM and contact angle measurements in comparison with the deposition of 
PEO directly on butyl rubber. The uniformity of these coatings is expected to translate 
into functional properties of the PEO, such as resistance to protein adsorption. In 
addition, the issue of delamination of RB from stainless steel surfaces was addressed by 
the introduction of the oxygenated functionalities. Specifically, the acid functionality 
increased the surface adhesion the greatest, demonstrating the promise of these materials 
in stent coating applications.  
 
3.4 Experimental 
Preparation of Films  
Silicon wafers (1 cm X 1 cm) were cleaned by immersion in H2O2/H2SO4 solution (3:1). 
They were then rinsed with deionized distilled water and dried at 100 °C. Polymer 1 in 
hexane (5 mg/mL) was spin coated onto a clean silicon wafer and then cross-linked by 
HHIC (see below). Polymer 3.2a, 3.3a, or 3.4a in hexane (5 mg/mL) was then spin coated 
onto the cross-linked butyl rubber (3.1a) surface and was then cross-linked by HHIC. 
PEO was then spin coated from CH2Cl2 onto cross-linked 3.1a, 3.2a, 3.3a or 3.4a and was 
then cross-linked by HHIC. In each of the above cases the polymer concentration was 5 
mg/mL and the spin coating conditions were 100 µL of polymer solution per cm2, at a 
spin rate of 6000 rpm for 30 seconds.  
Hyperthermal Hydrogen Induced Cross-linking (HHIC) 14  
Samples were inserted into a homemade HHIC reactor and pumped down to a 
background pressure of 2×10-6 Torr. Hydrogen gas was then introduced inside the reactor 
until a pressure of 8×10-4  Torr was reached and maintained throughout the experiment. 
An electron-cyclotron- resonance microwave plasma (87.5 mT, 2.45 GHz) was set up in a 
semi-permeable region of the reactor, enclosing the plasma with zero potential. Positive 
hydrogen ions were extracted through an applied potential difference of -96 V and 
accelerated into a drift zone, which is a 50 cm long electric field-free region. There they 
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underwent a series of binary collisions with molecular hydrogen in a stochastical manner. 
In order to calculate an average number of collision centers in the drift zone, the diameter 
of the hydrogen molecule was assumed to be 2.72 Å. For the given pressure and 
temperature = 20 °C, the average number of collision centers was calculated to be 4.3. 
Residual electrons and positive ions were repelled in two stages with an applied voltage 
of +60 V and -40 V respectively. Based on these values and an extraction current of 7 
mA, the fluence of hyperthermal neutrals was calculated to be 3 x 1016 per cm2, sufficient 
to cross-link the polymer by physical means. Under this set of conditions, the surface was 
exposed to hyperthermal molecular hydrogen with a nominal average kinetic energy of 5-
10 eV, an appropriate kinetic energy to break C-H bonds but not other bonds undesirably. 
The surfaces were treated for 30 to 100 seconds. 
Atomic Force Microscopy  
Surface morphology of the samples was imaged with the dynamic force mode using a 
Park Systems XE-100 atomic force microscope. A rectangular-shaped silicon cantilever 
(T300, VISTAprobes) was used, which has a nominal tip apex radius of 10 nm; spring 
constant of 40 N/m and resonant frequency of 300 kHz. The cantilever was vibrated 
around its resonant frequency and its reduced amplitude was used as the feedback 
parameter to image the sample surface. The measurements were carried out in air at room 
temperature. Film thickness was measured by scratching the laminate to the substrate and 
measuring the height difference from the top of the laminate to the substrate.   
Contact Angle Measurements   
A contact angle goniometer (Ramé-Hart’s Model 100-00 or Kruss DSA 100) was used. 
Surfaces were first loaded onto the stage and drops of distilled water (10 µL ) were 
placed on the specimens. The reported static angles were calculated by averaging the 
angles from both the left and right sides of the droplet. Advanced and receding contact 
angles were also evaluated. At least 10 measurements on each surface were obtained for 
each experimental condition. 
Surface Adhesion  
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Sample sheets were prepared by pressing a sheet of the same compound into a square 
woven fabric (canvas) in a mould for 5 minutes at 100 °C between Mylar and Teflon. The 
test strips were then died from the sheet and tested. The test specimens consisted of 6.35 
X 50.8 mm reinforced strips, the thickness of which varied from 0.5 to 3.3 mm. The test 
specimens were placed in the apparatus at right angles to each other and thus defined the 
area of contact. A 450 g weight was placed on the weight support, the dwell time was set 
to 60 seconds, and strips were died out with the Tel-Tak die. The stainless steel specimen 
was placed in the top platen; the Mylar was removed from the rubber surface and placed 
in the lower platen. The force gauge was zeroed. The lower platen was raised to make 
contact with the specimen in the upper platen. At the end of the dwell time period the 
drive motor began to pull the specimens apart and the force required for separation was 
recorded. 
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Chapter 4  
4 Conjugation and Release of Paclitaxel from Butyl 
Rubber films 
Contribution Statement: Toxicity testing was completed in collaboration with Bethany 
Turowec.  
4.1 Introduction  
Poly(isobutylene) (PIB) and its copolymers such as butyl rubber (RB) have been 
used for years in a number of different applications. Conventionally these synthetic 
elastomers have been used in the production of tires and various automotive parts due to 
desirable properties such as water/gas impermeability, chemical stability, high elasticity 
and thermal stability. Recently PIB and its copolymers have been identified for use in 
biomaterials. Currently these elastomers are used in chewing gum, pharmaceutical 
stoppers, and vascular stents1-3.  
 Vascular stents are employed when balloon angioplasty is used to clear blood 
vessels to retain the open form of the blood vessel. Without insertion of a stent, rapid 
restenosis occurs causing health implications4.  Bare metal stents (BMS) have been 
utilized to prevent the rapid restenosis but there have been long-term complications 
common with BMS such as restenosis and thrombosis5, 6. Recently, drug-eluting stents 
(DES) were developed in the hope that these long-term implications would be resolved.  
The metallic stent was coated with a durable elastomer and mixed with a loading of drug 
to eliminate cell growth on the surfaces of the stent. Boston Scientific commercialized the 
TAXUS stent, which has passed FDA regulations and is in clinical use today1. The stent 
utilizes poly(styrene)-co-poly(isobutylene)-co-poly (styrene) (SIBS) as the polymeric 
coating and paclitaxel (PTx) as drug. Over the past decade since they have been approved 
for clinical use, all of the studies have shown the drastic improvement in preventing 
events like restenosis and thrombosis7-9.  However, there are still issues in real world 
applications. Events of late thrombosis and restenosis are still observed in these DES, 
which has been accredited to delamination of the film from the stainless steel substrate as 
65 
 
well as erratic release of drug. Various weight percentages (wt.%) of SIBS compared to 
PTx have shown slow to fast release this however did not address the issue of 
delamination10. Recently Fausts’ group has synthesized modified SIBS polymers in the 
hope to control release. They synthesized styrene maleic anhydride (SMA) copolymers 
and blended it with traditional SIBS11. Upon studying the release of PTx they found that 
the higher amounts of SMA blended relative to SIBS gave an accelerated release of PTx. 
They also studied the synthesis of poly(methyl methacrylate-b-isobutylene-b-methyl 
methacrylate) and poly(hydroxystyrene-b-isobutylene-b-hydroxystyrene), which yielded 
a similar result to the SMA derivative studied12, 13.  
 Work has been completed on the modification of butyl rubber (RB) as a potential 
alternative to SIBS2, 3, 14. RB is typically polymerized with small amounts of isoprene (IP) 
(2.2-7%). Various functionalities have been installed along the RB backbone through its 
bromo-RB derivative but recently RB itself has been functionalized15-17.  Poly(ethylene 
oxide) (PEO) graft copolymers were synthesized using mild conditions and in high 
purity18, 19. One intermediate of specific interest is the allylic alcohol produced upon the 
ring opening of an epoxide. The allylic alcohol can be treated with a cyclic anhydride to a 
carboxylic acid functionalized RB as described in Chapter 2.  This acid derivative should 
serve as an excellent polymeric backbone to eliminate the issues inherent with the current 
TAXUS DES. Carboxylic acid moieties have shown increased adhesion to various 
substrates, metallic and natural. Also, the functional handle can be used to conjugate PTx 
to eliminate early burst release of drug. The following chapter will discuss the use of 
carboxylic acid functionalized RB to synthesize PTx conjugates as well as a preliminary 
drug release. The conjugates were studied chemically via NMR, IR, SEC, TGA and DSC. 
The release study was followed using HPLC, and surfaces were imaged using SEM and 
AFM.  
4.2 Results and Discussion  
As described in Chapter 2, reacting 4.1 with a cyclic anhydride can synthesize an 
acid functionalized RB. Diglycolic anhydride reacts to complete conversion to yield 4.2 
bearing carboxylic acid moieties to which PTx can be conjugated (Scheme 4.2.1). A 
similar approach has been used to produce monomethoxy-poly(ethylene glycol)-b-
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poly(lactide) conjugated with paclitaxel20. The conjugation of paclitaxel occurred through 
the use of dicyclohexylcarbodiimide (DCC) but in this study 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDCHCl) was employed. DCC byproducts were 
very problematic to remove due to their limited solubilities in comparison to those 
obtained using EDCHCl. To modify the wt.% of PTx two different IP content polymers 
were used in this study – a-2.2 mol% and b-7.0 mol%. These variations in the IP content 
will affect the wt.% of drug loaded onto the RB.  
 
 
Scheme 4.2.1 Schematic representation of the conjugation of PTx to the RB backbone. 
 Conjugation was successful of PTx was confirmed by 1H NMR spectroscopy 
(Figure 4.2.1). The spectrum illustrates the characteristic PTx and RB peaks. Upon closer 
examination of the RB-PTx conjugate, some very characteristic shifts were observed. The 
most obvious change was the disappearance of the peak at 4.81 ppm, which corresponds 
to the proton adjacent to the hydroxyl to which conjugation occurs. After conjugation this 
peak shifts to 5.60 ppm. Furthermore the peak at 5.80 ppm, which corresponds to the 
proton adjacent to the benzyl ring, shifts to 6.05 ppm (Figure 4.2.2). These peak 
assignments were assisted by comparison with previously reported PTx ester prodrugs21. 
There is still some unreacted acids remaining on the RB backbone but conjugation was 
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greater than >80%. Based on NMR analysis, the conjugate with the RB acid prepared 
from RB with 2.2 mol% IP containing ~24 wt.% PTx, while that prepared from the RB 
containing 7.0 mol% IP contained ~48 wt.% PTx. These samples are denoted as 2C and 
7C respectively.  
 
Figure 4.2.1  1H NMR spectra of the 4.3a showing all the peaks corresponding to both 
PTx and RB, the key peaks are assigned for PTx.  
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Figure 4.2.2 1H NMR spectra illustrating the key peak changes observed a) a mixture of 
PTx with 4.2a/b b) after conjugation of PTx to 4.3a/b. 
 Once PTx was confirmed to be on the RB backbone, the release profiles were of 
specific interest for DES. Thin films of the polymer were coated on polished stainless 
steel plates via drop casting. In addition to the conjugates 4.3a and 4.3b, containing 
different wt.% of PTx, several controls were also prepared. To demonstrate the effect of 
covalent conjugation, 4.2a and 4.2b were physically mixed with 24 and 48 wt% of PTx 
respectively and the mixtures were cast on the stainless steel. These physical mixtures are 
denoted 2P and 7P respectively. Also, two examples of SIBS with different amounts of 
styrene content (S1-10% and S2-20%) and 24 wt.% of physically encapsulated PTx were 
used as a comparison with the other systems (Table 4.2.1). The release studies were 
carried out using literature protocols7, 22, 23. Briefly, the release medium was pH 
controlled at 7.4 and contained Tween, which is a surfactant known to help solubilize 
PTx. The Tween ensures the PTx does not adhere to the glass during the release study.  
The medium was removed from each sample every 7 days for analysis and was replaced 
with fresh medium. 
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Table 4.2.1 Description of the samples used in the release study. 
Sample	  Name	   Polymer	  Composition	   PTx	  wt.%	   PTx	  immobilization	  
2C	   4.3a	   ~24	   Covalent	  
7C	   4.3b	   ~48	   Covalent	  
2P	   4.2a	   24	   Physical	  
7P	   4.2b	   48	   Physical	  
S1	   SIBS-­‐	  10%	  styrene	   24	   Physical	  
S2	   SIBS-­‐	  20%	  styrene	   24	   Physical	  
 The release rates of PTx from the different films were studied by HPLC. The 
HPLC procedure was adapted from literature protocols24. The limit of detection for the 
HPLC study was 0.2 µg/mL. As a result of this limit of detection, all the samples of the 
release medium had to be concentrated from 10 mL to 2 mL. Water was removed via 
lyophlization and then the samples were reconstituted in water and acetonitrile. It was 
found during this study that a portion of acetonitrile was needed to solubilize the PTx. 
The release profile can be seen in Figure 4.2.3. The profile is shown in cumulative mass 
of PTx released and it should be noted that some degradation products of PTx were also 
seen in the HPLC trace such as the known epimer25.  As expected, the covalently bound 
PTx samples showed a very sustained, slow release in comparison to the physically 
immobilized samples. The covalently bound PTx samples also showed slower release in 
comparison to the SIBS examples. As observed in other studies, the introduction of 
hydrophilic blocks increases the bursts release of PTx but in the examples where it was 
covalently bound, it is the contrary. This is a very encouraging sign for applications of 
these materials. The slow sustained release exhibited by the conjugated PTx samples 
eliminates the burst release of drug that limits the application of such polymers in DES.  
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Figure 4.2.3 Release study of PTx from the polymeric substrates completed using HPLC. 
Note: 2C and 7C overlap for much of the study.  
The covalently bound samples also exhibited enhanced film adhesion to the metal 
substrate in comparison to the controls. As seen in Figure 4.2.4 the delamination of the 
physically immobilized samples and the SIBS examples was observed over the 35 day 
incubation period.  Since the PTx is covalently bound to the RB there appears to be no 
phase separation (Figure 4.2.6 c/e) as seen with the physically encapsulated samples so 
there is no interference at the polymer-metal interface. The phase separation can clearly 
be seen in Figure 4.2.6 a/g for the S1 and 2P samples. The increased adhesion could also 
be attributed to the incomplete conjugation of PTx to the RB backbone. The incomplete 
conjugation would leave residual carboxylic acid groups that would increase the adhesion 
to the stainless steel plate. 
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Figure 4.2.4 a) left- S1 after 35 days showing delamination right- 2C at 35 days showing 
little or no delamination b) left- 2P at 35 days showing slight delamination right- 2C at 35 
days showing resilience with no or little delamination. 
 
The films were imaged by SEM (Figure 4.2.5) and AFM (Figure 4.2.6) to 
investigate their integrity throughout the release study. The SIBS example can be seen in 
Figure 4.2.5a&b. As shown by SEM, the initial film was very smooth and uniform. After 
35 days in the release medium, the film's integrity had decreased drastically. The surface 
became non-homogenous with what appeared to be a rippling of the film itself. When 
comparing it to the physically immobilized examples, again at the beginning a uniform 
film was observed but after 35 days the film integrity was much different (4.2.5d). There 
were cracks in the polymer surface that could be visualized all over the surface. Finally, 
when observing the covalently bound examples, the results were quite different. The 
initial films were smooth as in the other cases, but after 35 days there were tiny holes 
throughout the film, which is believed to be indicative of release (Figure 4.2.5 f&h). This 
was confirmed by observing the AFM topography images. AFM also showed hole 
formation in the polymer film (Figure 4.2.6 d/f).  
a)# b)#
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Figure 4.2.5 SEM images of polymer surfaces before and after the degradation study: a) 
S1 before degradation; b) S1 at 35 days; c) 2P before degradation; d) 2P at 35 days; e) 7C 
before degradation; f) 7C at 35 days; g) 2C before degradation; h) 2C at 35 days. All 
scale bars correlate to 500 µm. 
a)# b)#
d)#c)#
f)#e)#
g)# h)#
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Figure 4.2.6 AFM topography images of polymer surfaces before and after the 
degradation study: a) S1 before degradation; b) S1 at 35 days; c) 2C before degradation; 
d) 2C at 35 days; e) 7C before degradation; f) 7C at 35 days; g) 2P before degradation; h) 
2P at 35 days.  
a)# b)#
c)# d)#
f)#e)#
h)#g)#
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Toxicity studies were also performed to evaluate whether these surfaces would 
release toxic levels of PTx during a defined incubation period in cell culture media. First, 
each surface was incubated in cell culture medium at 37 °C for 24 hours. This medium 
was then added to cells at serial 2-fold dilutions. As a known non-toxic control, high-
density polyethylene (hdpe) was the negative control. Sodium dodecyl sulfate was used 
as a positive control and toxicity was detected at 0.2 µg/mL, demonstrating the efficacy 
of the assay in detecting toxicity. In addition, to detect the leaching of any potentially 
toxic molecules from the starting acid functionalized rubbers, 4.2a and 4.2b, and SIBS 
without PTx, these were also included in the study. As shown in Figure 4.2.7, most of the 
materials did not lead to any detectable toxicity, with only a few of the films exhibiting 
modest toxicity at the highest leachate concentrations. These surfaces were the physically 
immobilized PTx materials as well as the SIBS materials, which released PTx the most 
rapidly in the release study. It should be noted that although PTx is a very toxic drug, the 
amounts of PTx released over the 24-hour incubation period would still be extremely 
small. The controls did not exhibit any toxicity in this assay. This again supports the use 
of these materials for biomedical applications. 
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Figure 4.2.7 MTT assay in evaluation of the toxicity of the polymeric surfaces.  
4.3 Conclusions  
 The successful conjugation of PTx to acid functionalized RB was described and 
the release of PTx from films of the conjugates was studied. The release was followed 
using HPLC and various imaging techniques. The synthesized RB-PTx conjugates 
showed a substantial decrease in the burst release of PTx in comparison with previously 
reported systems. These polymers exhibited a much slower release than previously 
reported physical mixtures of drug and polymer. In addition, the RB-PTx covalent 
conjugates show enhanced integrity and adhesion to the metal substrate throughout the 
release study. Thus, this new PTx polymer conjugate serves a promising new stent 
coating material that warrants further investigation for the development of new medical 
devices.  
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4.4 Experimental  
 
Synthesis of 4.3a 
A dried sample of 4.2a prepared as described in chapter 2, was dissolved in dry toluene 
(10 g, 3.9 mmol of CO2H) and put under inert conditions. A solution of 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide) (EDC) (1.25 eq. per CO2H, 4.9 mmol, 0.76g),  and 
4-dimethylaminopyridine (DMAP) (0.5 eq. per CO2H, 1.95 mmol, 0.25g)  were dissolved 
in dry CH2Cl2 and added to the 4.2a. The solution was allowed to stir for 10-20 minutes 
prior to the addition of Paclitaxel (PTx) (1.1 eq. per CO2H, 4.29 mmol, 3.65g) dissolved 
in CH2Cl2.  The solution was left at room temperature overnight. The reaction mixture 
was then stripped of CH2Cl2 via rotary evaporation and then washed with DI water, 1M 
HCl and 1M NaHCO3, two times. Lastly the resultant solution was precipitated in ethanol 
and dried under vacuum. Conversion was calculated using 1H NMR. 1H NMR (400 MHz, 
CDCl3) 8.16 (PTx, d, 2H), 7.76 (PTx, d, 2H), 7.62 (PTx, m, 1H), 7.42-7.52 (PTx, m, 4H), 
7.28-7.41 (PTx, m, 8H), 6.90-7.02 (PTx, m, 1H), 6.31 (PTx, s, 2H), 6.05 (PTx, brs, 1H), 
5.71 (PTx, d, 1H), 5.60 (PTx, s, 1H), 5.23 (RB, brs, 1.4H), 5.09 (RB, d, 1.4H), 4.99 (PTx, 
d, 1.2H), 4.92 (RB, d, 1.6H), 4.06-4.47 (PTx, m, H), 3.83 (PTx, d, 1H), 2.49 (PTx, s, 4H), 
2.24 (PTx, s, 4H), 1.96 (PTx, s, 4H), 1.42 (RB, s, 316H), 1.12 (RB, s, 978H).  SEC: Mw = 
337000 g/mol, PDI = 1.47. IR 1232, 1367, 1390, 1475, 1670, 1737, 2960 cm-1. 
Synthesis of 4.3b 
Conjugate 4.3b was prepared as described above for 4.3a except that this polymer 
contained 1.2 mmol per g of CO2H and thus the amounts of EDC, DMAP and PTx were 
increased to retain these reagent ratios at 1.25, 0.5, and 1.1 equivalents per CO2H 
respectively. 1H NMR (400 MHz, CDCl3) .16 (PTx, d, 2H), 7.76 (PTx, d, 2H), 7.62 (PTx, 
m, 1H), 7.42-7.52 (PTx, m, 4H), 7.28-7.41 (PTx, m, 8H), 6.90-7.02 (PTx, m, 1H), 6.31 
(PTx, s, 2H), 6.05 (PTx, brs, 1H), 5.71 (PTx, d, 1H), 5.60 (PTx, s, 1H), 5.23 (RB, brs, 
1.4H), 5.09 (RB, d, 1.4H), 4.99 (PTx, d, 1.2H), 4.92 (RB, d, 1.6H), 4.06-4.47 (PTx, m, 
H),3.83 (PTx, d, 1H), 2.49 (PTx, s, 4H), 2.24 (PTx, s, 4H), 1.96 (PTx, s, 4H), 1.42 (RB, s, 
77 
 
111H), 1.12 (RB, s, 353H). SEC: Mw =501400 g/mol, PDI = 2.66. IR 1232, 1367, 1390, 
1475, 1670, 1737, 2960 cm-1. 
Preparation of Films  
The substrate chosen was a stainless steel plate with dimensions of 3 cm X 1 cm. The 
surface was polished with a bench-top grinder to give a smooth surface. To prepare the 
film, a 100 mg/mL solution (in CH2Cl2) of polymer was prepared. For the physically 
encapsulated samples, the PTx was added next at the appropriate weight percentage. A 
100-µL aliquot of each of the polymer solution was drop cast onto the stainless steel 
plate. The sample was dried under reduced pressure prior to the release study. Each 
sample was prepared and studied in triplicate. 
Release Study  
The release study was performed in 0.01 M phosphate buffered solution of pH= 7.4. The 
final buffer also contained 0.138 M NaCl and 0.0027 M KCl and also contained 0.05% 
Tween 20 as a surfactant. The stainless steel plates were placed into a vial containing 10 
mL of buffered solution. The solution was maintained at 37 °C and the buffer was 
removed every 7 days for analysis of PTx and replaced with fresh medium. Due to the 
low concentrations of PTx released, the release medium was concentrated prior to HPLC 
analysis. The water was removed via lyophilization and the solid was redissolved in 2 mL 
of 80:20 water:acetonitrile.  
HPLC protocol  
The HPLC instrument was equipped with a Waters Separations Module 2695, a 
Photodiode Array Detector (Waters 2998) and a Nova-Pak C18 4um (3.9x150mm) 
column connected to a C18 guard column. The PDA detector was used to monitor PTx at 
228 nm. PTx separation was obtained using a gradient method with Solvent A (5% 
acetonitrile in water) and Solvent B (80% acetonitrile, 0.1% H3PO4 in water) flowing at 
1mL/min.  Gradient of Solvent A 65% was decreased to 30% over 10 min, and increased 
back to 65% over the next 5 min where the column was allowed to equilibrate over 
another 5 min.  
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The calibration curve was obtained from Paclitaxel (LC Laboratories, >99%, P-9600) 
standard solutions. Stock solutions of 1000 µg/mL, 100 µg/mL and 50 µg/mL of PTx in 
acetonitrile were prepared. The stock solutions were used to make standard solutions of 
25, 20, 15, 10, 7.5, 5, 2, 1, 0.5 µg/mL in 20:80 acetonitrile:PBS solution. Standards were 
filtered and injected at 100 µL using the above instrument method. Samples were 
prepared in a 20:80 acetonitrile:PBS solution, filtered through 0.2 µm filters and injected 
at 100 µL using the same conditions as described above. The limit of detection of PTx 
was determined to be 0.02 µg.   
 
Atomic Force Microscopy 
Surface morphologies of the samples were imaged with the dynamic force mode using a 
Park Systems XE-100 atomic force microscope. A rectangular-shaped silicon cantilever 
(T300, VISTA probes) was used, which has a nominal tip apex radius of 10 nm, spring 
constant of 40 N/m and resonant frequency of 300 kHz. The cantilever was vibrated 
around its resonant frequency and its reduced amplitude was used as the feedback 
parameter to image the sample surface. The measurements were carried out in air at room 
temperature. Image processing was completed using XEI software developed by Park 
Systems.  
Scanning Electron Microscopy 
In all cases, all stainless steel plates were mounted on aluminum stubs with carbon tape, 
then sputter coated with gold. The surface microstructure was then imaged by scanning 
electron microscopy (SEM) (S- 2600N, Hitachi, Japan).  
Toxicity assay.  
Preparation of leachate: Test samples were melt-pressed to a thickness of 0.4 mm as 
described above. The melt pressed film was then cut into squares of 1 cm × 1 cm. 
Samples were sterilized by washing with 70% ethanol and subsequently dried for 2 hours 
under UV light. They were placed in Petri dishes and incubated in 2 mL of Dulbecco’s 
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Modified Eagle Medium (DMEM, Invitrogen) supplemented with 10% fetal bovine 
serum (Invitrogen) and supplemented with 1% Glutamax (100×) solution and 1% 
Penstrep (100×) in an incubator at 37°C for 24 hours. The leachate was then removed and 
passed through a 0.2 µm filter.  
MTT assay: C2C12 mouse myoblast cells were seeded in a Nunclon® 96-well U bottom 
transparent polystrol plate to obtain 10,000 cells/well in 100 µL of DMEM containing 
serum, glutamax and antibiotics as described above. The cells were allowed to adhere in a 
5% CO2 incubator at 37 °C for 24 hr. Next, the growth medium was aspirated and was 
replaced with either the positive control - sodium dodecyl sulfate (SDS) in the cell culture 
medium at concentrations of 0.2, 0.15, 0.10, or 0.05 mg/mL, serial two-fold dilutions of 
the leachate, or just the medium. The cells were then incubated at 37 °C (5% CO2) for 24 
h. The medium was then aspirated and replaced with 110 µL of fresh medium containing 
0.5 mg/mL (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) 
reagent. After 4 h of incubation (37 °C, 5% CO2), the MTT solution was carefully 
aspirated and the purple crystals were dissolved by addition of 50 µL of spectroscopic 
grade dimethylsulfoxide (DMSO). After shaking (1 second, 2 mm amp, 654 rpm), the 
absorbance of the wells at 540 nm was read using an M1000-Pro plate reader (Tecan). 
The absorbance of wells not containing cells but treated by all of the above steps was 
subtracted as a background and the cell viability was calculated relative to wells 
containing cells that were exposed to just culture medium. No (0%) cell viability was 
detected for the cells exposed to the highest concentrations of the positive control sodium 
lauryl sulfate, confirming the sensitivity of the assay. 
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Chapter 5  
5 Conclusions  
5.1 Concluding remarks and future directions 
The synthesis of functionalized butyl rubbers (RB) has significant importance in 
the expansion of its applications into different areas. As a result of these modifications, 
RB and its other copolymers can be utilized in the expanding field of biomaterials. The 
biomaterials market is currently expanding and RB should be a viable candidate for such 
applications. However, there are some limitations that can potentially be addressed 
through modification of the polymer backbone. In order to address some of these 
limitations, this thesis aimed at introducing carboxylic acid derivatives onto the RB 
backbone and using these to enhance the properties and application potential of RB. 
 In Chapter 2, the chemical functionalization of RB with acid moieties was 
described. The ring opening of diglycolic anhydride was a successful method for 
introducing individual carboxylic acid moieties along the backbone and this was applied 
to RB containing different isoprene contents to achieve different degrees of carboxylic 
acid functionalization along the backbone. ATRP was a successful approach for the 
introduction of poly(carboxylic acid) arms along the backbone to achieve even higher 
acid content. On the other hand, despite its widespread use, thiol-ene chemistry proved 
unsuccessful for the functionalization of RB.  
 In Chapter 3, the acid functionalized RB synthesized using the cyclic anhydride 
route was examined as a compatibilizer for the deposition of hydrophilic polymers on RB 
and for increased surface adhesion. When applied to the preparation of poly(ethylene 
oxide) (PEO) films on RB, it was found to behave similarly to the hydroxylated and 
epoxidized RB samples, providing compatibilization and thus more uniform films. It also 
provided enhanced adhesion to stainless steel. When compared to commercial RB, the 
acid functionalized RB showed greater than two times the adhesion to the stainless steel 
substrate.  
83 
 
 In Chapter 4, the use of carboxylic acid functionalized RB for the preparation of 
paclitaxel (PTx) conjugates was explored with the aim of slowing drug release for drug 
eluting stents. The acid functionalized via cyclic anhydride was conjugated with PTx via 
a carbodiimide coupling. Films on stainless steel substrates were prepared and compared 
with various controls that did not have the drug covalently conjugated. The conjugated 
samples showed very slow, sustained release in comparison to the other polymeric films 
used. Also it was observed that the conjugated samples showed increased adhesion to the 
stainless steel substrate suggesting the promise of these materials for further 
investigation.  
 With respect to future work, there are several aspects that warrant further 
investigation in the future. The PTx-RB conjugates were coated onto stainless steel plates 
in this study and it would be ideal to explore the coating on actual stents. The release of 
drug from the actual stents should then be studied. In addition, unlike the SIBS materials 
that are used clinically, the current materials are not thermoplastic elastomers and are not 
covalently cross-linked. Their physical properties should be studied and a means of cross-
linking the materials may need to be investigated. The poly(carboxylic acid) 
functionalized RB, synthesized using ATRP should be tested for increasing surface 
adhesions as well as producing PTx conjugates. For the application to DES, this project 
should also be directed towards applying these chemical techniques to the arborescent 
versions of RB, which are also promising materials for stent coatings.  
 
84 
 
Appendices  
 
 
Appendix A  1H NMR (400 MHz, CDCl3) of polymer 2.4b with the 7.0% IP RB.  
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Appendix B IR trace for polymer 2.4b with higher IP content (7%) RB.  
 
 
Appendix C left-DSC and right-TGA for polymer 2.4b. 
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Appendix D left-DSC and right-TGA for polymer 2.4a. 
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Appendix E  1H NMR (400 MHz, CDCl3) of thiol-ene attempts with dodecanethiol with 
polymer 2.3a. 
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Appendix F 1H NMR (400 MHz, CDCl3) of copolymer 2.10. 
 
Appendix G 1H NMR (400 MHz, CDCl3) of copolymer 2.11. 
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Appendix H 1H NMR (400 MHz, CDCl3) of copolymer 2.12. 
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Appendix I TGA analysis of polymer 2.8. 
91 
 
 
Appendix J TGA analysis of polymer 2.9.  
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Appendix K TGA analaysis of polymer 2.10.  
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Appendix L TGA analysis of 2.11. 
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Appendix M 1H NMR (400 MHz, CDCl3) of polymer 4.3b. 
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Appendix N SEC traces for the PTx conjugates 4.3a/b.  
0"
0.2"
0.4"
0.6"
0.8"
1"
8" 9" 10" 11" 12" 13" 14" 15" 16" 17" 18"
Elu$ons(Time((min.)(
2.2"IP"+"Taxol"
7.0"IP"+"Taxol"
96 
 
 
Appendix O Calibration curve for the release study of paclitaxel via HPLC. 
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Appendix P Representative HPLC trace for release study. 
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Appendix Q TGA analysis of PTx conjugate 4.3b. 
 
Appendix R TGA analysis of PTx conjugate 4.3a. 
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Appendix S IR trace of PTx conjugate of 4.3a. 
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